Focus: Philips is a Dutch multinational medical devices and healthcare technology company with 10,000+ employees, headquartered in Amsterdam. The company operates across imaging, monitoring, and therapeutic device categories with a diverse portfolio spanning cardiology, respiratory, and oncology.
Profile data last refreshed 50m ago · AI intelligence enriched 2mo ago
Hot — 2371 jobs added in 30d
Net +696 (2371 new, 1675 removed). Aggressive expansion phase.
Strong career choice if you want device innovation scale with corporate stability, but less suitable for those seeking exposure to high-risk, high-reward clinical breakthroughs.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Multiple variants (Auto, AutoSV Advanced, Synchrony) indicate mature, high-volume respiratory franchise supporting recurring patient adherence.
Help build intelligence for Philips
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Philips's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Phase 3 validation for uterine fibroids indicates targeted advancement; image-guided intervention represents high-margin specialty application.
Multiple AI-enhanced reconstruction algorithms and deep-learning features suggest continuous platform evolution maintaining competitive moat.
Multiple catheter-based platforms with novel imaging guidance (electromagnetic tracking, KODEX-EPD) position Philips as interventional procedure enabler.
AI is boosting accuracy for clinicians, Philips North America CEO says - Reuters
AI is boosting accuracy for clinicians, Philips North America CEO says Reuters
Exton's West Pharmaceutical Services Names New CEO as Eric Green Steps Down After 11 Years - VISTA.Today
Exton's West Pharmaceutical Services Names New CEO as Eric Green Steps Down After 11 Years VISTA.Today
West Pharmaceutical names Michel Lagarde as next CEO - Investing.com
West Pharmaceutical names Michel Lagarde as next CEO Investing.com
The Best Healthcare Stocks to Buy - Morningstar
The Best Healthcare Stocks to Buy Morningstar
8-K Filing: TuHURA Biosciences, Inc./NV (HURA) (CIK 0001498382) — 8-K
8-K
Trump unveils 100% tariff on some patented drugs on 'Liberation Day' anniversary - KSAT
Trump unveils 100% tariff on some patented drugs on 'Liberation Day' anniversary KSAT
Showing 6 of 10 news items
Based on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo